Alnylam Pharmaceuticals Inc. (ALNY): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Alnylam Pharmaceuticals ( ALNY) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.1%. By the end of trading, Alnylam Pharmaceuticals rose $27.07 (40.9%) to $93.28 on heavy volume. Throughout the day, 5,330,206 shares of Alnylam Pharmaceuticals exchanged hands as compared to its average daily volume of 667,700 shares. The stock ranged in a price between $84.76-$112.57 after having opened the day at $85.36 as compared to the previous trading day's close of $66.21. Other companies within the Health Care sector that increased today were: IsoRay ( ISR), up 75.6%, Rexahn Pharmaceuticals ( RNN), up 40.4%, Oragenics ( OGEN), up 32.4% and Hemispherx Biopharma ( HEB), up 24.1%.

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). Alnylam Pharmaceuticals has a market cap of $4.1 billion and is part of the drugs industry. Shares are up 3.0% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Alnylam Pharmaceuticals a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Alnylam Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share.

On the negative front, Intercept Pharmaceuticals ( ICPT), down 18.3%, Conatus Pharmaceuticals ( CNAT), down 17.3%, Geron Corporation ( GERN), down 13.8% and Corcept Therapeutics ( CORT), down 13.1% , were all laggards within the health care sector with Celgene Corporation ( CELG) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Ford, GM Gain as China Slashes Auto Import Tariffs

Ford, GM Gain as China Slashes Auto Import Tariffs

U.S. Crude Oil Hits Fresh 3-Year Highs as Gasoline Heads to $3 a Gallon

U.S. Crude Oil Hits Fresh 3-Year Highs as Gasoline Heads to $3 a Gallon